Leerink Partners analyst Daina Graybosch maintained a Buy rating on Nkarta (NKTX – Research Report) yesterday and set a price target of $7.00.

Leerink Partners analyst Daina Graybosch maintained a Buy rating on Century Therapeutics (IPSC – Research Report) yesterday and set a price ...

Leerink Partners analyst Daina Graybosch cautioned against too much pessimism, writing “this continued uncertainty is likely driving more downside than warranted.” The issues with Gardasil sales in ...

Daina Graybosch, Leerink Partners: Asked about WINREVAIR’s HYPERION trial outcomes. Dean Li stated the trial was stopped early due to overwhelming efficacy, reinforcing the drug’s ...

On Jan. 30, Leerink Partners analyst Daina Graybosch maintained a “Buy” rating on MRK with a price target of $118, implying a potential upside of 18.2% from current levels. The mean price ...

Rahway, New Jersey-based Merck & Co., Inc. (MRK) functions as a healthcare company. Valued at $252.4 billion by market cap, the company delivers health solutions through its prescription medicines, ...

Q4 2024 Management View Rob Davis emphasized Merck's strong performance in 2024, driven by demand for KEYTRUDA, the launch of WINREVAIR, and robust growth in Animal Health. Davis highlighted ...

VIENTIANE: The Indochina Bank has officially launched its latest product, the ‘Daina Pay’, to facilitate transactions including the payment of urgent bills. The bank’s managing director ...

Academy Award-nominated actor John Lithgow is reportedly closing in on a deal to play Headmaster Albus Dumbledore in the upcoming HBO Harry Potter series. Celebrity AI video protests Kanye West ...

Cindy Perettie; Executive Vice President of Kite; Gilead Sciences Inc. Geoffrey Meacham; Analyst; Citi. Terence Flynn; Analyst; Morgan Stanley. Timothy Anderson; Analyst; BofA Glo ...

Gilead Sciences, Inc. ( NASDAQ: GILD) Q4 2024 Earnings Conference Call February 11, 2025 4:30 PM ET Jacquie Ross - SVP, Treasury & IR Daniel O'Day - Chairman, CEO Johanna Mercier - Chief Commercial ...